Skip to main content

Rhythm Pharmaceuticals Inc(RYTM-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Rhythm Pharmaceuticals Inc

222 BERKELEY STREET 12TH FLOOR
BOSTON MA 02116 USA
P: 857-264-4280
F: 857-264-4299
http://www.rhythmtx.com

Profile

Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company. It focused on the development and commercialization of peptide therapeutics for the treatment of rare genetic deficiencies which result in life-threatening metabolic disorders. The Company's product candidate principally consists of setmelanotide, a potent, first-in-class melanocortin-4 receptor or MC4R, agonist for the treatment of rare genetic disorders of obesity. Rhythm Pharmaceuticals, Inc. is based in Boston, MA.

Key Executives

NameTitle
David P. MeekerCEO/Chairman of the Board/Director/President
Hunter C. SmithCFO/Treasurer
Yann MazabraudExecutive VP/Other Corporate Officer
Jennifer LeeExecutive VP/Other Corporate Officer
Pamela J. CramerOther Executive Officer
Joseph ShulmanChief Technology Officer